Clinical trial

Trazodone/Gabapentin Fixed Dose Combination Products in Painful Diabetic Neuropathy

NCT03749642

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-11-22

PhasePHASE2

Study timeline

Study start (actual)2018-11-22Date precision: day

Registry last updated2021-05-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Painful Diabetic Neuropathyunresolved

Interventions

trazodone/gabapentin 2.5/25 mgDRUG

trazodone/gabapentin 5/50 mgDRUG

trazodone/gabapentin 10/100DRUG

GabapentinDRUG · verified · RxNorm: gabapentin

Placebo oral capsuleDRUG

Sponsors & collaborators

Aziende Chimiche Riunite Angelini Francesco S.p.Alead sponsor

Chiltern International Inc.collaborator

Mapped research locations

ManchesterUnited Kingdom2 BirminghamUnited Kingdom1 SheffieldUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03749642 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.